Back

De-escalation strategy with half-dose prasugrel or ticagrelor on pharmacodynamics and outcome in East Asians patients with acute coronary syndrome

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Acute Coronary Syndromes ePosters Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Moo Hyun Kim

Dong-a University Hospital, Busan (Korea (Republic of))

238 More presentations in this session

Presentation thumbnail
Prevalence of thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries and cryptogenic stroke
Miss S. Kruchinova (Krasnodar, RU)
Abstract Slides
Presentation thumbnail
Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome
Doctor M. Centola (Desio, IT)
Abstract Slides
Presentation thumbnail
Clinical predictors and angiographic features of acute coronary syndromes caused by systemic embolism
Mr A. Jeronimo (Madrid, ES)
Abstract Slides
Presentation thumbnail
Morphological characteristics of plaque erosion with noncritical coronary stenosis: an optical coherence tomography study
Doctor C. Fang (Harbin, CN)
Abstract Slides
Presentation thumbnail
Metformin exerts cardioprotection via attenuating mitochondrial fission in cardiac ischaemia-reperfusion injury in rats
Doctor T. Clements (Chiang Mai, TH)
Abstract Slides

Access the full session

Session thumbnail
Acute Coronary Syndromes ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Long-term outcomes of prasugrel-based de-escalation versus conventional therapy after PCI in ACS patients
1 September 2025
thumbnail
Congress Presentation
Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis
1 September 2020
thumbnail
Congress Presentation
Is there an inter-manufacturer difference in generic clopidogrel response?
26 August 2022
thumbnail
Congress Presentation
Prasugrel versus ticagrelor in ST-elevation myocardial infarction, a real-world cohort
25 March 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources